imatinib mesylate has been researched along with Stenosis, Pulmonary Vein in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baird, CW; Callahan, R; Colan, SD; Gauvreau, K; Ireland, CM; Jenkins, KJ; Kieran, MW; Marshall, AC; Sena, LM; Vargas, SO | 1 |
1 trial(s) available for imatinib mesylate and Stenosis, Pulmonary Vein
Article | Year |
---|---|
Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis.
Topics: Angiogenesis Inhibitors; Bevacizumab; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imatinib Mesylate; Male; Prospective Studies; Protein Kinase Inhibitors; Stenosis, Pulmonary Vein; Treatment Outcome | 2018 |